Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage
Clinical trial NCT00905034 · COMPLETED
Trial details
- NCT number
- NCT00905034
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2015-02-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.